*Kazuya Takeda¹, Toshiki Himeda², Tomonori Kaifu¹, Yoshiro Ohara³, Akira Nakamura¹ (1. Tohoku Medical and Pharmaceutical University, 2. Kanazawa Medical University, 3. AOIKAI SENDAI Hospital)

*Tomoyuki Shiota^1,2, Masamichi Muramatsu¹, Stanley M. Lemon² (1. Foundation for Biomedical Research and Innovation at Kobe, 2. The University of North Carolina at Chapel Hill)

*Kyousuke Kobayashi¹, Namiko Nomura¹, Ayako Ohkubo¹, Tomoha Nishizawa¹, Satoshi Koike¹ (1. Tokyo Metropolitan Institute of Medical Science)

*Ijaz Ahmad¹, Fumitaka Sato¹, Seiichi Omura¹, Sundar Khadka¹, Ah-Mee Park¹, Felicity N.E. Gavins², Ikuo Tsunoda¹ (1. Kindai University Faculty of Medicine , 2. Brunel University London)

*Georgelin Nguema Ondo¹, Yuri Ushijima², Haruka Abe², Bertrand Lell¹, Jiro Yasuda² (1. CERMEL, Gabon, 2. Institute of Tropical Medicine, Nagasaki University)

*Takafumi Noguchi^1,2, Anju Miyamori¹, Paola Miyazato^1,2, Sayuri Komatsu^1,2, Ryo Sasaki^1,2, Hirotaka Ebina^1,2 (1. Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan, 2. The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan)